Genentech , Inc.

Industry:	Pharmaceuticals, Biotechnology, Drug Manufacturing & Research
Ranking:	Russell 3000
Revenues:	$11.7 Billion
Employees:	11,174

Description

Genentech, Inc. (Genentech) is a biotechnology company that discovers, develops, manufactures and commercializes pharmaceutical products to treat patients with unmet medical needs. It commercializes multiple biotechnology products and also receives royalties from companies that are licensed to market products based on the Company’s technology. Genentech commercializes various products in the United States, including Avastin, Rituxan, Herceptin, Lucentis, Xolair, Tarceva, Nutropin, Activase, TNKase, Cathflo Activase, Pulmozyme and Raptiva. The Company’s licensed products include Trastuzumab, Rituximab, Bevacizumab, Dornase alfa, recombinant, Alteplase and Tenecteplase, Somatropin, Daclizumab, Ranibizumab, Etanercept, Adalimumab and Infliximab. As of July 21, 2008, Roche Holding Ltd. held a 55.9% interest in Genentech, Inc., a biotechnology company.

Find More Jobs

Job Openings

Bioassay QC Scientist South San Francisco , CA

Head of Modeling & Simulation South San Francisco , CA

Senior Project Manager- Companion Diagnostics South San Francisco , CA

QA Principal I (Associate Director) South San Francisco , CA

Scientist (Technology) - Assay & Automation Technology South San Francisco , CA

View More Statistics

Site Statistics

Monthly Unique Visitors:	69,413
Site Rank:	28,737
Trust Rating:	Trusted
Stats by

News Archive

Genentech ramping up north county manufacturing: drug maker says it plans to increase work force to 500-plus.(BIOTECH) San Diego Business Journal; 8/3/2009 ...responsible for producing batches of Genentech's best-selling cancer drug Avastin...businesses' manufacturing sites worldwide, Genentech said last week. Employees, however...Sanders, previously senior director of Genentech's South San Francisco manufacturing... ...more

Genentech, Seattle Genetics Collaborate In Antibody Program. BIOWORLD Today; 11/4/2009 Washington Editor Genentech Inc. will strengthen its long-standing...technology to build its cancer program. Genentech, of South San Francisco, licensed...o she said. Seattle Genetics and Genentech already enjoy a relationship via development... ...more

Another Earnings Home Run: Genentech 'Can Do No Wrong'. BIOWORLD Today; 11/4/2009 ...23 percent increase in product sales, Genentech Inc. chalked up earnings in the second...per share. "It's a situation where Genentech can do no wrong," said Ronald Renaud...early June, South San Francisco-based Genentech disclosed much-lauded positive data... ...more